You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
9lione raises ¥120M in Series A funding led by Yokohama Capital to enhance its digital transformation platform for pharmaceutical distribution.
PRIVATESep 14, 2026•about 3 hours ago
Amount Raised
¥120 Million
Round Type
Series A
JapanBiotechnologyHealth Care
Investors
Angel InvestorsNanobankGlobe AdvisorsMitsui Sumitomo Insurance CapitalDg VenturesIncubate FundYokohama Capital
Description
9lione, based in Nerima-ku, Tokyo, has raised ¥120 million in Series A funding, bringing its total funding to ¥440 million. The funding will be used to expand the company's logistical network and develop AI-driven products for medical institutions. The round was led by Yokohama Capital, with participation from multiple investors. Founded in 2018, 9lione aims to alleviate pharmaceutical supply shortages through efficient redistribution of unused medicines.
Company Information
Company
9lione
Location
Japan
About
9lione is a company based in Nerima-ku, Tokyo, that operates a digital transformation platform aimed at improving pharmaceutical distribution. It connects hospitals with surplus medications to those experiencing shortages, while also managing inventory and traceability. Founded in 2018, 9lione functions as a licensed pharmaceutical wholesaler, reducing waste and alleviating supply shortages. The company focuses on developing AI-driven solutions for medical institutions.
Don't miss 9lione's next move
Get an email the moment 9lione raises, hires an exec, or expands, usually minutes after it happens.